SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Discussion centers on Lillys obesity and diabetes franchise and expectations for quarterly results, with traders pointing to Mounjaro and Zepbound demand, Foundayo uptake, and pipeline prospects. Bulls cite growth and healthcare-sector strength, while skeptics flag Lillys high valuation and competition from Novo Nordisk and emerging obesity-drug rivals.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharply reduced third-quarter outlook, driven by weak demand, excess distributor inventory and a major pricing reset, has intensified concerns about its business and heavy debt. Traders are divided between viewing the reset and debt-reduction measures as a path to recovery and fearing further deterioration or bankruptcy.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Discussion centers on whether Teladoc can show a credible turnaround in its quarterly results, especially stabilizing BetterHelp as it shifts from cash-pay to insurance amid concerns about declining revenue, profitability and management execution. Bulls cite potential insurance growth, Teladoc One and short-interest dynamics, while skeptics remain doubtful; squeeze claims are speculative.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens attention is centered on Phase 3 results showing IMDELLTRA with AstraZenecas IMFINZI reduced the risk of death in first-line extensive-stage small-cell lung cancer. Traders are treating the survival findings as a positive oncology catalyst, while some also point to favorable Phase 3 TEZSPIRE results in eosinophilic esophagitis.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Speculation that Johnson & Johnson could acquire Sellas Life Sciences is a recurring topic, with traders pointing to alleged executive connections and J&Js oncology ambitions; no deal has been confirmed. Traders are also debating J&Js earnings reaction: stronger-than-expected results and raised guidance were offset by weak MedTech growth and litigation concerns, while some view the pullback as a buying opportunity.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas oncology and rare-disease pipeline is drawing attention, with traders highlighting the U.S. launch of lung-cancer drug Zegfrovy, an accelerated FDA approval for Ultomiris in IgA nephropathy, and positive trial updates. Reactions are mixed between optimism about new treatment opportunities and concern about recent trial setbacks and share-price weakness.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons breakout to record highs is drawing attention as firm crude prices and Middle East supply concerns support energy stocks, with traders also positioning ahead of the companys earnings report. Sentiment is largely bullish around the momentum, though some caution that the rally is extended and the results could test whether it can hold.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

The ongoing shale-oil antitrust case is drawing attention after the judge deferred jurisdictional rulings for Hess and Pioneer pending limited discovery, with an October status conference ahead; traders emphasize that the claims remain unresolved. Bullish chatter also points to oil-linked strength and a possible technical breakout, though some traders are watching resistance.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is drawing attention around GameStops nearly 10% stake and its rejected takeover bid, with traders debating whether GameStop will renew its acquisition push, seek a partnership or board influence, or step back. Speculation is tempered by doubts about financing and deal merits, while some traders also cite eBays earnings and analyst support.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is drawing attention amid volatile crude prices and Middle East supply concerns, especially reports involving Iran and Strait of Hormuz shipping. Traders are bullish on the potential benefit to producers but debate why energy shares often lag oil, while ceasefire and deal speculation has raised concerns that the geopolitical risk premium could fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Psychedelic Supplier Climbs 20% After Filament Ships PEX010 Into the EU

Pharmaceutical-grade botanical psilocybin that clears a European QP release is the kind of supply milestone academic sponsors actually need before dosing starts. Investigator-led studies in the EU lean on standardized natural material with documented quality systems, not retail truffle branding, so each cleared shipment is a demand signal for the few suppliers that can meet that bar.Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) rose Thursday after announcing that wholly owned Filament Health completed a shipment of PEX010 into the European Union, released through its European QP, in ...

Clinical Breakthrough: Repeat Psilocybin Dosing Drives Lasting Improvements for Cancer Patients

Most clinical trials in psychedelic medicine have traditionally focused on the impact of a single treatment session. However, new data published this month is shifting that narrative, suggesting that psilocybin therapy may be more effective when structured as a repeatable, protocol-driven treatment rather than a one-time intervention. As regulatory pathways for these therapies accelerate, the focus is moving toward optimizing dosing schedules to maximize long-term patient outcomes.&nbsp;Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) released details today of a Phase 1 clinical study ...

Rhelion Life Sciences Corp. engages in the production and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a psilocybin truffle to the legal, recreational market within the Netherlands. It operates through the following geographical segments: Netherlands, Canada, and United States. The company was founded by Todd Michael Shapiro on September 29, 1982 and is headquartered in Toronto, Canada.

Rhelion Life Sciences Corp.

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

Red Light Holland Corp

$TRUFF The FDA may soon approve its first psychedelic drug. But how to regulate it? 
The agency plans to fast-track applications for several psychedelics, but it must also create a set of rules about who can take and administer them and in what settings

Feed

News

Sentiment

Earnings

Fundamentals

Info

TRUFF Red Light Holland Corp

Fundamentals

Latest TRUFF News